Design and development of innovative Bi-specific antibodies
In this webinar, Dr. Li Chen of ProBio will introduce therapeutic antibodies, focusing on the opportunities and challenges of current monotherapy. We analyze the major benefits of bispecific antibodies and the current formats used in clinical trials. Additionally, we share an in-depth, integrated SMAB (single-domain antibody fused to monoclonal antibody) case study from rational design to preclinical development.
Topics that will be covered:
- The advantages of bi-specific antibody therapy
- Challenges in bi-specific antibody development and solutions
- Case study of ProBio’s SMABodyTM platform
